193 related articles for article (PubMed ID: 19165719)
1. Residual structure within the disordered C-terminal segment of p21(Waf1/Cip1/Sdi1) and its implications for molecular recognition.
Yoon MK; Venkatachalam V; Huang A; Choi BS; Stultz CM; Chou JJ
Protein Sci; 2009 Feb; 18(2):337-47. PubMed ID: 19165719
[TBL] [Abstract][Full Text] [Related]
2. The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition.
Esteve V; Canela N; Rodriguez-Vilarrupla A; Aligué R; Agell N; Mingarro I; Bachs O; Pérez-Payá E
Chembiochem; 2003 Sep; 4(9):863-9. PubMed ID: 12964161
[TBL] [Abstract][Full Text] [Related]
3. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of p21(Waf1/Cip1/Sdi1) C-terminal domain bound to Cdk4.
Sung YH; Shin J; Shin J; Lee W
J Biomol Struct Dyn; 2001 Dec; 19(3):419-27. PubMed ID: 11790141
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of the Arabidopsis thaliana proliferating cell nuclear antigen 1 and 2 proteins complexed with the human p21 C-terminal segment.
Strzalka W; Oyama T; Tori K; Morikawa K
Protein Sci; 2009 May; 18(5):1072-80. PubMed ID: 19388052
[TBL] [Abstract][Full Text] [Related]
7. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
[TBL] [Abstract][Full Text] [Related]
8. Calcium binding and conformational properties of calmodulin complexed with peptides derived from myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP).
Porumb T; Crivici A; Blackshear PJ; Ikura M
Eur Biophys J; 1997; 25(4):239-47. PubMed ID: 9112755
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection.
Wang W; Nacusi L; Sheaff RJ; Liu X
Biochemistry; 2005 Nov; 44(44):14553-64. PubMed ID: 16262255
[TBL] [Abstract][Full Text] [Related]
10. A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo.
Chen J; Peters R; Saha P; Lee P; Theodoras A; Pagano M; Wagner G; Dutta A
Nucleic Acids Res; 1996 May; 24(9):1727-33. PubMed ID: 8649992
[TBL] [Abstract][Full Text] [Related]
11. Distinct pools of proliferating cell nuclear antigen associated to DNA replication sites interact with the p125 subunit of DNA polymerase delta or DNA ligase I.
Riva F; Savio M; Cazzalini O; Stivala LA; Scovassi IA; Cox LS; Ducommun B; Prosperi E
Exp Cell Res; 2004 Feb; 293(2):357-67. PubMed ID: 14729473
[TBL] [Abstract][Full Text] [Related]
12. p21 Exploits Residue Tyr151 as a Tether for High-Affinity PCNA Binding.
Kroker AJ; Bruning JB
Biochemistry; 2015 Jun; 54(22):3483-93. PubMed ID: 25972089
[TBL] [Abstract][Full Text] [Related]
13. Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.
Scott MT; Morrice N; Ball KL
J Biol Chem; 2000 Apr; 275(15):11529-37. PubMed ID: 10753973
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the C-terminal region of human myelin basic protein and calmodulin: analysis of complex formation and solution structure.
Majava V; Petoukhov MV; Hayashi N; Pirilä P; Svergun DI; Kursula P
BMC Struct Biol; 2008 Feb; 8():10. PubMed ID: 18284662
[TBL] [Abstract][Full Text] [Related]
15. Utility of peptide-protein affinity complexes in proteomics: identification of interaction partners of a tumor suppressor peptide.
Gururaja TL; Li W; Payan DG; Anderson DC
J Pept Res; 2003 Apr; 61(4):163-76. PubMed ID: 12605602
[TBL] [Abstract][Full Text] [Related]
16. A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics.
Zheleva DI; Zhelev NZ; Fischer PM; Duff SV; Warbrick E; Blake DG; Lane DP
Biochemistry; 2000 Jun; 39(25):7388-97. PubMed ID: 10858286
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation.
Asada M; Yamada T; Ichijo H; Delia D; Miyazono K; Fukumuro K; Mizutani S
EMBO J; 1999 Mar; 18(5):1223-34. PubMed ID: 10064589
[TBL] [Abstract][Full Text] [Related]
18. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
Chen J; Jackson PK; Kirschner MW; Dutta A
Nature; 1995 Mar; 374(6520):386-8. PubMed ID: 7885482
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription.
Kitaura H; Shinshi M; Uchikoshi Y; Ono T; Iguchi-Ariga SM; Ariga H
J Biol Chem; 2000 Apr; 275(14):10477-83. PubMed ID: 10744738
[TBL] [Abstract][Full Text] [Related]
20. Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA.
Gulbis JM; Kelman Z; Hurwitz J; O'Donnell M; Kuriyan J
Cell; 1996 Oct; 87(2):297-306. PubMed ID: 8861913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
